Amicus Therapeutics: Q3 Earnings Snapshot
In this article:
PHILADELPHIA (AP) — PHILADELPHIA (AP) — Amicus Therapeutics Inc. (FOLD) on Wednesday reported a loss of $21.6 million in its third quarter.
On a per-share basis, the Philadelphia-based company said it had a loss of 7 cents.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 8 cents per share.
The pharmaceutical company posted revenue of $103.5 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $100.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FOLD at https://www.zacks.com/ap/FOLD
